Form 8-K - Current report:
SEC Accession No. 0001437749-26-009063
Filing Date
2026-03-19
Accepted
2026-03-19 16:17:46
Documents
21
Period of Report
2026-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20260319_8k.htm   iXBRL 8-K 43551
2 EXHIBIT 4.1 ex_935004.htm EX-4.1 93067
3 EXHIBIT 4.2 ex_935005.htm EX-4.2 94934
4 EXHIBIT 4.3 ex_935006.htm EX-4.3 94654
5 EXHIBIT 5.1 ex_935003.htm EX-5.1 12558
6 EXHIBIT 10.1 ex_935007.htm EX-10.1 208518
7 EXHIBIT 10.2 ex_935008.htm EX-10.2 51748
8 EXHIBIT 99.1 ex_935009.htm EX-99.1 10624
9 EXHIBIT 99.2 ex_935010.htm EX-99.2 11246
14 image01.jpg GRAPHIC 13564
  Complete submission text file 0001437749-26-009063.txt   920207

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA rvph-20260318.xsd EX-101.SCH 3579
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20260318_def.xml EX-101.DEF 11424
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20260318_lab.xml EX-101.LAB 15310
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20260318_pre.xml EX-101.PRE 11584
24 EXTRACTED XBRL INSTANCE DOCUMENT rvph20260319_8k_htm.xml XML 2879
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 26774459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)